O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy.
Saved in:
| Title: | O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy. |
|---|---|
| Authors: | Ross, P.1, Hendlisz, A.2, Ajithkumar, T.3, Iwuji, C.4, Harris, M.5, Croagh, D.5, Aghmesheh, M.6, Nagrial, A.7, Nguyen, N.8, Nikfarjam, M.9, Wilson, N.10, Kenny, D.10, Turner, D.11, Wasan, H.12 |
| Source: | Annals of Oncology. 2020 Supplement 3, Vol. 31, p232-232. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
